Dai W - Search Results

1

Receptor mediated transcytosis in biological barrier: The influence of receptor character and their ligand density on the transmembrane pathway of active-targeting nanocarriers.

Song X, Li R, Deng H, Li Y, Cui Y, Zhang H, Dai W, He B, Zheng Y, Wang X, Zhang Q. Song X, et al. Among authors: dai w. Biomaterials. 2018 Oct;180:78-90. doi: 10.1016/j.biomaterials.2018.07.006. Epub 2018 Jul 5. Biomaterials. 2018. PMID: 30025247

2

PHSCNK-Modified and doxorubicin-loaded liposomes as a dual targeting system to integrin-overexpressing tumor neovasculature and tumor cells.

Dai W, Yang T, Wang X, Wang J, Zhang X, Zhang Q. Dai W, et al. J Drug Target. 2010 May;18(4):254-63. doi: 10.3109/10611860903353354. J Drug Target. 2010. PMID: 19824864

3

Materializing sequential killing of tumor vasculature and tumor cells via targeted polymeric micelle system.

Wang Y, Yang T, Wang X, Dai W, Wang J, Zhang X, Li Z, Zhang Q. Wang Y, et al. Among authors: dai w. J Control Release. 2011 Feb 10;149(3):299-306. doi: 10.1016/j.jconrel.2010.10.027. Epub 2010 Oct 31. J Control Release. 2011. PMID: 21044651

4

Targeted delivery of a combination therapy consisting of combretastatin A4 and low-dose doxorubicin against tumor neovasculature.

Yang T, Wang Y, Li Z, Dai W, Yin J, Liang L, Ying X, Zhou S, Wang J, Zhang X, Zhang Q. Yang T, et al. Among authors: dai w. Nanomedicine. 2012 Jan;8(1):81-92. doi: 10.1016/j.nano.2011.05.003. Epub 2011 May 20. Nanomedicine. 2012. PMID: 21664295

5

Monitoring the transport of polymeric micelles across MDCK cell monolayer and exploring related mechanisms.

Zhao S, Dai W, He B, Wang J, He Z, Zhang X, Zhang Q. Zhao S, et al. Among authors: dai w. J Control Release. 2012 Mar 28;158(3):413-23. doi: 10.1016/j.jconrel.2011.12.018. Epub 2011 Dec 29. J Control Release. 2012. PMID: 22226779

6

Peptide PHSCNK as an integrin α5β1 antagonist targets stealth liposomes to integrin-overexpressing melanoma.

Dai W, Yang T, Wang Y, Wang X, Wang J, Zhang X, Zhang Q. Dai W, et al. Nanomedicine. 2012 Oct;8(7):1152-61. doi: 10.1016/j.nano.2012.01.003. Epub 2012 Jan 31. Nanomedicine. 2012. PMID: 22306158

7

Novel cathepsin B-sensitive paclitaxel conjugate: Higher water solubility, better efficacy and lower toxicity.

Liang L, Lin SW, Dai W, Lu JK, Yang TY, Xiang Y, Zhang Y, Li RT, Zhang Q. Liang L, et al. Among authors: dai w. J Control Release. 2012 Jun 28;160(3):618-29. doi: 10.1016/j.jconrel.2012.02.020. Epub 2012 Mar 3. J Control Release. 2012. PMID: 22410114

8

A novel lanreotide-encoded micelle system targets paclitaxel to the tumors with overexpression of somatostatin receptors.

Zheng N, Dai W, Du W, Zhang H, Lei L, Zhang H, Wang X, Wang J, Zhang X, Gao J, Zhang Q. Zheng N, et al. Among authors: dai w. Mol Pharm. 2012 May 7;9(5):1175-88. doi: 10.1021/mp200464x. Epub 2012 Mar 30. Mol Pharm. 2012. PMID: 22435704

9

A cremophor-free self-microemulsified delivery system for intravenous injection of teniposide: evaluation in vitro and in vivo.

He S, Cui Z, Mei D, Zhang H, Wang X, Dai W, Zhang Q. He S, et al. Among authors: dai w. AAPS PharmSciTech. 2012 Sep;13(3):846-52. doi: 10.1208/s12249-012-9809-0. Epub 2012 May 30. AAPS PharmSciTech. 2012. PMID: 22644709 Free PMC article.

10

Spatiotemporally controlled co-delivery of anti-vasculature agent and cytotoxic drug by octreotide-modified stealth liposomes.

Dai W, Jin W, Zhang J, Wang X, Wang J, Zhang X, Wan Y, Zhang Q. Dai W, et al. Pharm Res. 2012 Oct;29(10):2902-11. doi: 10.1007/s11095-012-0797-2. Epub 2012 Jun 22. Pharm Res. 2012. PMID: 22723122

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,978 results

Search Page

Filters